A PROSPECTIVE RANDOMIZED, DOUBLE-BLIND, CONTROLLED
TRIAL OF NERVE HYDRODISSECTION FOR CARPAL TUNNEL
SYNDROME |
|
| Language |
English |
| Corres.Author |
Nandyala Sreekar |
| Email |
Nandyala@gmail.com |
| Accepted Date |
|
| File size |
|
| No of Downloads |
155 |
| Published by |
IJCPCR |
| Full Text |
 |
|
| The authors propose to inject objects between the median nerve and the transverse carpal ligament, as well as the lower
tendons, to break the central nerve attachment and reduce symptoms. After complete knee arthroplasty, the same procedure
was used to treat carpal tunnel syndrome, lateral femoral cutaneous neuropathy and infrapatellar saphenous neuralgia with
positive effects. All test results were performed by one investigator who was unaware of the assignment or medical
information. Pre-intervention testing and post-intervention testing were performed at 1, 2, 3, and 6 months. Data from the
upper hand were used to measure outcomes in patients who underwent both side effects. The results revealed that both
groups had improved signal strength, performance status level and cross-sectional area in all follow-up tests (p0.05)
compared to baseline. In a 2-year follow-up study, 25 percent and 47.6 percent of untreated people with Carpal Tunnel
Syndrome experienced electrophysiological development and symptomatic recovery, respectively. Neurological
hydrodissection may be evaluated in the future compared with established care procedures, such as isolation, physical
therapy, and corticosteroid injection, and its effect on patients with Carpal Tunnel Syndrome adherence after surgery or
failed surgery can be investigatedddd |
